ConvaTec Group PLC (LON:CTEC) Receives Consensus Recommendation of “Moderate Buy” from Analysts

ConvaTec Group PLC (LON:CTEC) has been assigned a consensus rating of “Moderate Buy” from the nine research firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is GBX 306.

A number of research firms have issued reports on CTEC. Berenberg Bank restated a “buy” rating and issued a GBX 340 target price on shares of ConvaTec Group in a report on Tuesday, April 21st. Jefferies Financial Group reiterated a “buy” rating and set a GBX 300 price target on shares of ConvaTec Group in a report on Monday, June 8th. JPMorgan Chase & Co. cut their price objective on shares of ConvaTec Group from GBX 307 to GBX 294 and set an “overweight” rating for the company in a research report on Friday, May 22nd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 315 price objective on shares of ConvaTec Group in a research note on Wednesday, April 8th. Finally, UBS Group restated a “buy” rating and set a GBX 375 target price on shares of ConvaTec Group in a research report on Monday, May 18th.

Insider Buying and Selling at ConvaTec Group

In other ConvaTec Group news, insider Jonny Mason purchased 50,000 shares of ConvaTec Group stock in a transaction on Tuesday, May 26th. The shares were bought at an average price of GBX 201 per share, with a total value of £100,500. 0.98% of the stock is currently owned by corporate insiders.

ConvaTec Group Stock Up 0.3%

CTEC opened at GBX 215.80 on Wednesday. The firm has a market cap of £4.22 billion, a P/E ratio of 25.09, a PEG ratio of 0.93 and a beta of 0.76. The business’s fifty day simple moving average is GBX 208.38 and its 200 day simple moving average is GBX 222.41. ConvaTec Group has a 52 week low of GBX 193 and a 52 week high of GBX 259.30. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 99.96.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.